Roger R. Taylor

9.3k citations

126 papers · 7.4k indexed · 2 hit papers · h-index 40

Cardiology and Cardiovascular Medicine top 0.2%
Complementary and alternative medicine top 0.05%
Surgery top 2%
Physiology top 1%
Endocrinology, Diabetes and Metabolism top 2%

Co-authors: Daniel J. Green Andrew Maiorana G. O’Driscoll Gerry O’Driscoll Craig Cheetham Cyril Mamotte Anthony D. Jose Carmél Goodman
Topics: Cardiovascular Function and Risk Factors (20 papers)Cardiac electrophysiology and arrhythmias (17 papers)Lipoproteins and Cardiovascular Health (13 papers)
Cited by: Complementary and alternative medicine Cardiology and Cardiovascular Medicine Physiology
Journals: New England Journal of Medicine Circulation Journal of Clinical Investigation
Partner nations: Australia United States Serbia

In The Last Decade

Roger R. Taylor

123 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month

1997 795 citations G. O’Driscoll, Daniel J. Green et al. profile →
Effect of exercise training on endothelium‐derived nitric oxide function in humans

2004 760 citations Daniel J. Green, Andrew Maiorana et al. profile →

Peers

Countries citing papers authored by Roger R. Taylor

Since Specialization

Citations

This map shows the geographic impact of Roger R. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger R. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger R. Taylor more than expected).

Fields of papers citing papers by Roger R. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger R. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger R. Taylor. The network helps show where Roger R. Taylor may publish in the future.

Co-authorship network of co-authors of Roger R. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Roger R. Taylor. A scholar is included among the top collaborators of Roger R. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger R. Taylor. Roger R. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Effect of Isoniazid Administration on the Blood Ammonia in Tuberculous Patients1 2015 ·American Review of Respiratory Disease ·Z.Z. Ziporin,John Chambers,Roger R. Taylor,(unknown)	0
2	Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease 2003 ·Atherosclerosis ·(unknown),(unknown),Els Thiry,Fred Van Leuven,Roger R. Taylor,Cyril Mamotte	24
3	Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function 2003 ·Atherosclerosis ·William Bilsborough,Daniel J. Green,Cyril Mamotte,Frank M. van Bockxmeer,G. O’Driscoll,Roger R. Taylor	26
4	The Poliovirus Receptor Related 2 (PRR2) and Apolipoprotein E Genes and Coronary Heart Disease 2002 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Elizabeth Freitas,(unknown),Carly E. Herbison,Frank Christiansen,Roger R. Taylor,F. M. van Bockxmeer	10
5	Evidence of reduced coronary artery disease risk for apolipoprotein ϵ2/3 heterozygotes 2002 ·European Journal of Internal Medicine ·Cyril Mamotte,Valerie Burke,Roger R. Taylor,Frank M. van Bockxmeer	11
6	Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population 2001 ·European Journal of Cardiovascular Prevention & Rehabilitation ·(unknown),Roger R. Taylor,F. M. van Bockxmeer,Cyril Mamotte	86
7	The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes 2001 ·Journal of the American College of Cardiology ·Andrew Maiorana,G. O’Driscoll,Craig Cheetham,L. Dembo,K. Stanton,Carmél Goodman,Roger R. Taylor,Daniel J. Green	376
8	Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes 2000 ·Journal of the American College of Cardiology ·Craig Cheetham,Julie Collis,G. O’Driscoll,K. Stanton,Roger R. Taylor,Daniel J. Green	103
9	Improvement in endothelial function by angiotensin-converting enzyme inhibition in non–insulin-dependent diabetes mellitus 1999 ·Journal of the American College of Cardiology ·G. O’Driscoll,Daniel J. Green,Andrew Maiorana,K. G. Stanton,Frances Colreavy,Roger R. Taylor	134
10	The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle 1998 ·Atherosclerosis ·(unknown),Cyril Mamotte,Frank M. van Bockxmeer,Roger R. Taylor	66
11	Lack of Effect of Vitamin E Administration on Basal Nitric Oxide Function in Male Smokers and Non-Smokers 1995 ·Clinical Science ·Daniel J. Green,Gerry O’Driscoll,Brian Blanksby,Roger R. Taylor	20
12	Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency. 1993 ·PubMed ·(unknown),Mark A. Ireland,(unknown),Roger R. Taylor	26
13	PLASMA PHOSPHOLIPASE A₂ ACTIVITY IN CLINICAL ACUTE MYOCARDIAL INFARCTION 1992 ·Clinical and Experimental Pharmacology and Physiology ·(unknown),Marian Sturm,(unknown),(unknown),Roger R. Taylor	15
14	The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog 1992 ·Journal of Molecular and Cellular Cardiology ·(unknown),Marian Sturm,J. M. Papadimitriou,(unknown),Roger R. Taylor	10
15	The Edwardian reformation, 1547-1553 : a study of the clerical reformers' vision for the Church of England and English society 1990 ·UMI Dissertation Services eBooks ·Roger R. Taylor	1
16	Effect of α1-adrenoceptor blockade on ventricular ectopic beats in acute myocardial infarction 1990 ·International Journal of Cardiology ·Challon J. Murdock,(unknown),(unknown),(unknown),Roger R. Taylor	4
17	SHORT TERM VITAMIN E SUPPLEMENTATION HAS NO EFFECT ON PLATELET FUNCTION, PLASMA PHOSPHOLIPASE A₂ AND LYSO‐PAF IN MALE VOLUNTEERS 1990 ·Clinical and Experimental Pharmacology and Physiology ·Peter L. Silbert,(unknown),Marian Sturm,(unknown),Roger R. Taylor	19
18	Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease 1985 ·The American Journal of Cardiology ·(unknown),(unknown),Roger R. Taylor	25
19	Randomized controlled trial of vasodilator therapy after myocardial infarction 1981 ·The American Journal of Cardiology ·(unknown),Geoffrey D. Cope,Geoffrey M. Clarke,Roger R. Taylor	23
20	Theoretical analysis of the isovolumic phase of left ventricular contraction in terms of cardiac muscle mechanics 1970 ·Cardiovascular Research ·Roger R. Taylor	16

About Roger R. Taylor

Roger R. Taylor is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Surgery, having authored 126 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (20 papers), Cardiac electrophysiology and arrhythmias (17 papers) and Lipoproteins and Cardiovascular Health (13 papers). The work is most often cited by research in Complementary and alternative medicine (1.7k citations), Cardiology and Cardiovascular Medicine (4.6k citations) and Physiology (1.5k citations). Roger R. Taylor has collaborated with scholars based in Australia, United States and Serbia. Frequent co-authors include Daniel J. Green, Andrew Maiorana, G. O’Driscoll, Gerry O’Driscoll, Craig Cheetham, Cyril Mamotte, Anthony D. Jose, Carmél Goodman, Frank M. van Bockxmeer and James W. Covell. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact